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Protein N-glycosylation is an important post-translational modification and has influences 
on a variety of biological processes at the cellular and molecular level, making glycosylation 
a major study aspect for glycoprotein-based therapeutics. To achieve a comprehensive 
understanding on how N-glycosylation impacts protein properties, an Fc-fusion anthrax 
decoy protein, viz rCMG2-Fc, was expressed in Nicotiana benthamiana plant with three 
types of N-glycosylation profiles. Three variants were produced by targeting protein to plant 
apoplast (APO), endoplasmic reticulum (ER) or removing the N-glycosylation site by a point 
mutation (Agly). Both the APO and ER variants had a complex-type N-glycan (GnGnXF) as 
their predominant glycans. In addition, ER variant had a higher concentration of mannose-
type N-glycans (50%). The decoy protein binds to the protective antigen (PA) of anthrax 
through its CMG2 domain and inhibits toxin endocytosis. The protein expression, sequence, 
N-glycosylation profile, binding kinetics to PA, toxin neutralization efficiency, and thermostability 
were determined experimentally. In parallel, we performed molecular dynamics (MD) 
simulations of the predominant full-length rCMG2-Fc glycoform for each of the three 
N-glycosylation profiles to understand the effects of glycosylation at the molecular level. The 
MAN8 glycoform from the ER variant was additionally simulated to resolve differences 
between the APO and ER variants. Glycosylation showed strong stabilizing effects on 
rCMG2-Fc during in planta accumulation, evidenced by the over 2-fold higher expression 
and less protein degradation observed for glycosylated variants compared to the Agly variant. 
Protein function was confirmed by toxin neutralization assay (TNA), with effective concentration 
(EC50) rankings from low to high of 67.6 ng/ml (APO), 83.15 ng/ml (Agly), and 128.9 ng/ml 
(ER). The binding kinetics between rCMG2-Fc and PA were measured with bio-layer 
interferometry (BLI), giving sub-nanomolar affinities regardless of protein glycosylation and 
temperatures (25 and 37°C). The protein thermostability was examined utilizing the PA 
binding ELISA to provide information on EC50 differences. The fraction of functional ER 
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INTRODUCTION
Anthrax is a severe infectious disease caused by Bacillus anthracis. 
The spores can be  produced easily and released in air as a 
biological weapon, leading to a fatality rate of 86–89% (Kamal 
et  al., 2011). Bacillus anthracis secrets anthrax toxin, which is 
composed of a cell-binding protein, namely protective antigen 
(PA), and two enzymatic proteins called lethal factor (LF) and 
edema factor (EF). The cellular toxicity starts with the binding 
of PA to anthrax toxin receptors, after which the bound PA 
is cleaved by a furin family protease, leaving a 63 kDa fragment 
bound to the receptors (Wigelsworth et al., 2004). The receptor-PA 
complex then self-assembles into a heptamer (PA)7, allowing 
binding of LF and EF, which is then internalized to the cytosol 
through endocytosis, causing disruption to normal cellular 
physiology (Wigelsworth et  al., 2004). Antitoxins based on 
receptor-decoy binding show promising advantages over an 
antibody-based strategy since it is difficult to engineer toxins 
to escape the inhibitory effect of the decoy without compromising 
binding to its cellular receptor. By making the extracellular 
domain of the main anthrax toxin receptor Capillary 
Morphogenesis Gene 2 protein recombinantly (rCMG2), that 
can be  used as a prophylaxis or post-exposure treatment, to 
neutralize anthrax toxins in blood, preventing cell infection. 
Additionally, fusing an Fc domain to rCMG2 increases the 
serum half-life through interaction with the salvage neonatal 
Fc-receptor (Roopenian and Akilesh, 2007) and lowers renal 
clearance rate (Knauf et al., 1988). These factors make rCMG2-Fc 
a promising anthrax decoy protein, which retains the high 
binding affinity to the PA along with a longer blood circulatory 
half-life than rCMG2 (Wycoff et  al., 2011; Xi et  al., 2014; 
Karuppanan et  al., 2017). We  used a plant-based expression 
system for protein expression due to its rapid production rate 
and inherent scalability, which is critical for providing rapid 
response under emergency conditions. Moreover, plants rarely 
carry animal pathogens and are capable of post-translational 
modification, making them an appealing alternative to traditional 
protein expression systems such as mammalian cell culture or 
microbial fermentation (Chen and Davis, 2016).
N-glycosylation can affect protein folding, structural integrity, 
and function (Mimura et  al., 2000; Krapp et  al., 2003), which 
makes it an important design consideration for glycoprotein-
based therapeutics. In some cases, proteins with proper 
glycosylation exhibit optimal efficacy. For example, Fc glycosylation 
is required to elicit effector functions of human IgG1 
(Hristodorov et  al., 2013). Thus, it should be  preserved when 
immune defense is desired, for instance, when expressing anti-
tumor mAbs (Strome et  al., 2007). On the other hand, for 
drugs that treat chronic conditions, the absence of glycosylation 
is desired to avoid effector functions and associated inflammatory 
responses. Another important consideration is that glycosylated 
proteins are less susceptible to proteases, such as pepsin, compared 
with aglycosylated counterparts (Niu et al., 2016), which should 
be  considered to maximize protein yield.
Although the impacts of protein N-glycosylation have been 
studied, typically only one or two aspects were studied at a 
time, and these studies were done on antibodies (Raju and 
Scallon, 2006; Kayser et  al., 2011; Zheng et  al., 2011). This 
study provides a comprehensive approach utilizing a combination 
of experimental and computational techniques to evaluate the 
effects of N-glycosylation on rCMG2-Fc fusion protein properties. 
In this study, the protein expression, toxin neutralization efficacy, 
binding kinetics, thermostability, and structural configuration 
were studied experimentally and compared among three 
rCMG2-Fc glycoform variants. In addition, we employ atomistic 
molecular dynamics (MD) simulation to understand the structure 
and dynamics of the predominant glycoform of the APO, ER, 
and Agly variants. Atomistic MD simulations are well-suited 
for the study of biomolecular systems, providing full accessibility 
to virtual, high-resolution, time-ordered, atomic trajectories 
(Dror et  al., 2012). MD simulations have been used to study 
many different biological systems, including lipid membranes, 
trans-membrane proteins, and other glycoproteins (Nury et al., 
2010; Delemotte and Tarek, 2012; Bernardi et  al., 2017). While 
fully atomistic protein simulation is a powerful tool to investigate 
structural and functional information, it is important to recognize 
the current limitations of the technique. In particular, protein 
folding is known to occur on the order of microseconds to 
seconds (Dill and MacCallum, 2012), while atomistic protein 
simulation is generally limited to hundreds of nanoseconds 
due to limited computing resources. This limitation generally 
prohibits the straightforward simulation of protein fold 
transitions. The length-scale of atomistic protein simulations 
is also computationally restricted, allowing only one rCMG2-Fc 
dimer to be  simulated. Despite these limitations, this work 
shows MD simulation data is capable of providing insight into 
the effects of glycosylation on protein structure, and improving 
our understanding and interpretation of experimental 
observations. To the best of our knowledge, no study has been 
conducted on Fc-fusion protein considering that many 
variant decayed after overnight incubation at 37°C, and no significant change was observed 
for APO or Agly variants. In MD simulations, the MAN8 glycoform exhibits quantitatively 
higher distance between the CMG2 and Fc domains, as well as higher hydrophobic solvent 
accessible surface areas (SASA), indicating a possibly higher aggregation tendency of the 
ER variant. This study highlights the impacts of N-glycosylation on protein properties and 
provides insight into the effects of glycosylation on protein molecular dynamics.
Keywords: anthrax decoy protein, N-glycosylation, molecular simulation, protein stability, 
kinetics of protein binding
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experimental and molecular simulation factors. This study 
provides an integrated experimental and computational approach 
to evaluate Fc N-glycosylation impacts on rCMG2-Fc properties, 
and potentially serves as a guideline for general glycoprotein-
based therapeutic design, especially for Fc-fusion proteins.
MATERIALS AND METHODS
Gene Constructs
The codon optimized CMG2-Fc sequence includes the 
extracellular domain of CMG2 (amino acids 34–220, Genbank: 
AY233452), followed by two serine residues, the upper hinge 
of IgG2 (amino acids 99–105, Genbank: AJ250170.1), and Fc 
region of human IgG1 (amino acid 108–329, Genbank: 
AAC82527.1). The resulting sequence corresponds to the APO 
variant as described previously (Karuppanan et  al., 2017). A 
SEKDEL C-terminal motif was included to make the ER variant; 
a point mutation of N268Q on Fc was included to make the 
Agly variant. The genes encoding rCMG2-Fc variants were 
codon-optimized for expression in Nicotiana benthamiana. The 
full construct consists of the CaMV 35S promoter, Ω leader 
sequence, gene encoding the Ramy3D signal peptide, followed 
by rCMG2-Fc gene and octopine synthase terminator (details 
in Supplementary Figure S1). Agrobacterium tumefaciens (A. 
tumefaciens) EHA105 with the helper plasmid (pCH32) was 
transfected with the resulting binary expression vectors separately 
via electroporation. A binary vector capable of expressing P19 
to suppress RNAi-mediated gene silencing in Nicotiana 
benthamiana plants was co-infiltrated with the rCMG2-Fc-APO 
binary vector as previously described (Arzola et  al., 2011).
Transient Protein Expression in  
Nicotiana benthamiana
Protein was produced through whole-plant agroinfiltration as 
described previously (Xiong et  al., 2018), only differed from the 
plant age and the A. tumefaciens cell densities. Briefly, A. tumefaciens 
strains containing the rCMG2-Fc expression cassette and RNA 
gene silencing suppressor P19 were suspended into the infiltration 
buffer (10 mM MES buffer at pH 5.6, 10 mM MgCl2 and 150 μM 
acetosyringone, and 0.02% v/v Silwet-L-77) with a final cell density 
of 0.25 (A600) for each strain. Then, 5-weeks old Nicotiana 
benthamiana plants were vacuum infiltrated with the A. tumefaciens 
suspension for 1  min after vacuum pressure reaches 20  mm 
inches Hg. Infiltrated plants were incubated at 20°C growth 
chamber for 6  days allowing protein expression.
Plant Tissue Collection, Extraction, and 
Purification
Plant tissue was collected at day 6 after infiltration. To evaluate 
the average expression level, leaves from 10 plants were collected 
and stored at −80°C prior to extraction. Leaves were ground 
to fine powder using mortar and pestle with liquid nitrogen. 
The leaf powder was weighted and mixed with extraction buffer 
(1X PBS, 1  mM EDTA, and 2  mM sodium metabisulfite) at 
a leaf mass (g) to buffer volume (ml) ratio of 1:7. The mixture 
was incubated on a shaker at 4°C for 1 h and then centrifuged 
at 1,800g at 4°C for 1  h, followed by 0.22  μm filtration to 
remove insoluble particles. Filtered plant extract was loaded 
to protein A column and eluted with glycine-HCl buffer at 
pH of 3.0. Purified protein was immediately titrated to neutral 
pH with 1  M tris buffer, and buffer exchanged to 1X PBS 
through overnight dialysis at 4°C.
ELISA Quantification of rCMG2-Fc in 
Crude Plant Extracts
Expression of rCMG2-Fc in crude plant extract was quantified 
by a sandwich ELISA. First, ELISA microplate (Corning, Corning, 
NY) wells were coated with Protein A (Southern Biotech, 
Birmingham, AL) at a concentration of 50  μg/ml in 1X PBS 
buffer for 1 h, followed with plate blocking with 5% nonfat milk 
in 1X PBS buffer for 20  min. Crude plant extracts and purified 
standards (Planet biotechnology, Hayward, CA) were loaded to 
the plate and incubated from 1  h (starting from 0.05  μg/ml, 
3-fold serial dilutions). The bound rCMG2-Fc was detected by 
incubating a horseradish peroxidase (HRP)-conjugated goat anti-
human IgG (Southern Biotech, Birmingham, AL) at a concentration 
of 0.5  μg/ml for 1  h. Plates were washed three times with 1X 
PBST (1X PBS with 0.05% v/v of Tween20) between each of 
these steps. All incubation steps were done at 37°C, with an 
incubation volume of 50  μl. Next, 100  μl of ELISA colorimetric 
TMB substrate (Promega, Fitchburg, WI) was added to each 
well and incubated for 10  min, followed by the addition of 
100  μl of 1  N HCl to stop the reaction. The absorbance at 
450  nm was measured with a microplate reader (Molecular 
Devices, San Jose, CA). The absorbance of protein standard was 
plotted as a function of rCMG2-Fc concentration, and was fitted 
to the 4-parameter model in SoftMax Pro software. The 
concentration of rCMG2-Fc in crude plant extract was determined 
by interpolating from the linear region of the standard curve.
SDS-PAGE and Western Blotting
SDS-PAGE and Western blot analyses were performed on purified 
(protein A) rCMG2-Fc variants. Protein was denatured and 
reduced by treating samples at 95°C for 5  min with 5% (v/v) 
of 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO). For 
nonreducing SDS-PAGE, samples were denatured by heat treatment 
at 95°C for 5 min. Samples were loaded to precast 4–20% SDS-Tris 
HCl polyacrylamide gels (Bio-Rad Laboratories, Hercules, CA), 
running at 200 V for 35 min. For SDS-PAGE, the gel was washed 
three times with water and stained with Coomassie Brilliant 
Blue R-250 Staining Solution (Bio-Rad Laboratories, Hercules, 
CA). For Western blot analysis, samples were transferred to a 
nitrocellulose membrane by electrophoretic transfer using the 
iBlot Gel Transfer Device (ThermoFisher, Waltham, MA). For 
Western blot detecting the CMG2 domain, the membrane was 
probed with a goat anti-CMG2 polyclonal antibody (ThermoFisher, 
Waltham, MA) at a concentration of 0.3  μg/ml, followed by 
incubation of a polyclonal AP-conjugated rabbit anti-goat IgG 
antibody (Sigma-Aldrich, St. Louis, MO) at 1:10,000 dilution. 
For Western blot detecting the Fc domain, the membrane was 
incubated with a polyclonal AP-conjugated goat anti-human IgG 
antibody (Southern Biotech, Birmingham, AL) at 1:3,000 dilution. 
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The blots were developed using SIGMAFAST BCIP/NBT (Sigma-
Aldrich, St. Louis, MO) according to the product instruction.
SDS-PAGE Densitometry
CMG2-Fc standard from Planet Biotechnology (0.5, 0.75, 1.0, 
1.25, and 1.5  μg/lane) and rCMG2-Fc variants (APO, ER, and 
Agly) were reduced, denatured, and run on a 4–12% Bis-Tris 
gel (Invitrogen, Carlsbad, CA) gel at 50  mA for 1.5  h. After 
staining for 1  h with Coomassie Brilliant Blue R-250 staining 
solution (Bio-Rad Laboratories, Hercules, CA), the gel was 
washed with water overnight. Next morning, the gel was scanned 
with Gel Doc™ XR+ System (Bio-Rad laboratories, Hercules, 
CA), and a standard curve was established by plotting total 
protein mass of standards as a function of band intensity. 
Then, the band intensity for the ~50  kDa band of rCMG2-Fc 
variants was interpolated onto the standard curve to determine 
the mass of intact rCMG2-Fc, and calculate their concentrations.
Protein Sequence Identification  
by Liquid Chromatography-Tandem Mass 
Spectrometry (LC-MS/MS)
Purified rCMG2-Fc variants were subjected to protein sequence 
identification by mass spectrometry (LC-MS/MS). First, 10  μg 
of purified rCMG2-Fc variants were subjected to SDS-PAGE 
analyses under reducing conditions as described in SDS-PAGE 
and Western Blotting section. After staining the gel in Coomassie 
Brilliant Blue R-250 (Bio-Rad, Hercules, CA, USA) and rinsing 
in water, the rCMG2-Fc protein band was excised from the gel 
and submitted to the Proteomics Core facility of University of 
California, Davis for LC-MS/MS-based protein identification. 
Briefly, the protein was digested with sequencing grade trypsin 
per manufacturer’s recommendations (Promega, Madison, WI, 
USA). Specific conditions can be found on UC Davis Proteomics 
Core Facility website1 (“Ingel Digestion Protocol 2”). Peptides 
were dried using vacuum concentrator and resolubilized in 2% 
acetonitrile/ 0.1% trifluoroacetic acid. Peptides were analyzed 
by LC-MS/MS on a Thermo Scientific Q Exactive Orbitrap Mass 
Spectrometer in conjunction Proxeon Easy-nLC II HPLC and 
Proxeon nanospray source. The digested peptides were loaded 
on a Magic C18 200  Å 3  U reverse phase column 
(75-micron × 150  mm) and eluted using a 90-min gradient 
with a flow rate of 300 nl/min. An MS survey scan was obtained 
for the m/z range 300–1,600, spectra of MS/MS were developed 
using a top 15 method. An isolation mass window (2.0  m/z) 
was used for the precursor ion selection, and normalized collision 
energy (27%) was used for fragmentation. Tandem MS spectra 
were extracted and charge state deconvoluted by Proteome 
Discoverer (Thermo Scientific, Asheville, NC, USA). The MS/
MS samples were analyzed using X! Tandem (The GPM, thegpm.
org; version TORNADO (2013.02.01.1)). X! Tandem was set up 
to search UniProt-Nicotiana benthamiana_database (20140416, 
1,538 entries), the cRAP database of common laboratory 
contaminants2 (114 entries) plus an equal number of reverse 
1 https://proteomics.ucdavis.edu/protocols-2/
2 www.thegpm.org/crap
protein sequences assuming the trypsin enzyme digestion. Scaffold 
Proteome Software version 4.0.6.1 (OR, USA) was used to confirm 
protein identifications. X! Tandem identifications required at 
least –Log (Expect Scores) scores of greater than 1.2 with a 
mass accuracy of 5  ppm. Protein identifications were accepted 
if they contained at least two identified peptides. Using the 
parameters above, the Decoy False Discovery Rate (FDR) was 
calculated to be  4.5% on the protein level and 1.94% on the 
spectrum level. Proteins that contained similar peptides and 
could not be differentiated based on MS/MS analysis alone were 
grouped to satisfy the principles of parsimony.
Protein N-Glycoform Analysis by Dynamic 
Multiple Reaction Monitoring
rCMG2-Fc protein dissolved in 50 mM NH4HCO3 was denatured 
with 2 μl of dithiothreitol (DTT) in a 65°C water bath for 50 min, 
followed by the alkylation with 4  μl of iodoacetamide (IAA) in 
the dark for 20  min. The protein was then digested with 1  μg 
of trypsin in a 37°C water bath for 18  h. After the digestion, 
the mixture was frozen at −20°C for 1 h to deactivate the trypsin. 
For N-glycosylation analysis, 2  μl of the mixture was separated 
with an Agilent Eclipse plus C18 column (RRHD 1.8 μm, 2.1 mm 
× 150 mm) coupled to an Agilent Eclipse plus C18 guard column 
(RRHD 1.8  μm, 2.1  mm × 5  mm), using a 10-min-gradient 
where solvent A with 0.1% formic acid (FA) and 3% of ACN in 
water, and solvent B with 0.1% of FA and 90% of ACN in water 
were used for separation. The analysis was conducted on an Agilent 
1290 infinity ultra-high-pressure liquid chromatography (UHPLC) 
system coupled to an Agilent 6495 triple quadrupole (QQQ) mass 
spectrometer, which was operated in a dynamic multiple reaction 
monitoring (dMRM) mode. The glycosylation site of the protein 
is on the infused IgG Fc region so that the transition list used 
here was adapted from the dMRM method of serum IgG, the 
development of which was described in great details in the study 
conducted by Hong et  al. (2013). To modify the method for 
rCMG2-Fc glycosylation quantitation, the plant N-glycan 
compositions containing xylose rather than sialic acid were used. 
In total, nearly 30 unique transitions for targeted glycopeptides 
and peptides of the rCMG2-Fc protein composed of the precursor 
ion, the product ion, the collision energy, and the retention time 
for each individual compound of the protein were developed for 
the dMRM method. The targeted glycopeptides were selected as 
precursor ions and several common oxonium fragments with m/z 
values as 204.08 and 366.14 were used as product ions. The 
software used for data analysis was Agilent MassHunter Quantitative 
Analysis B.05.02 software. To calculate the relative abundance of 
each glycopeptide, the abundance of individual glycopeptide was 
normalized to the abundance of the quantitating peptide.
To validate the glycopeptides quantitated with the dMRM 
method, glycoproteomic analysis was conducted on rCMG2-Fc 
proteins. After the trypsin digestion of protein samples, 
glycopeptides were enriched with iSPE-HILIC cartridges. Then 
enriched samples were dried completely and reconstitute with 
30  μl of water for LC-MS/MS analysis. One microgram of 
sample was separated with a Thermo Acclaim PepMap RSLC 
C18 column using a 180-min gradient. The analysis was 
conducted on a Thermo UltiMate 300 nano LC system coupled 
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to an Orbitrap Fusion Lumos Tribrid mass spectrometer. The 
collected raw data were inspected with the software FreeStyle 
and the MS/MS spectra were search with the software Byonic.
Toxin Neutralization Assay
Cell viability was determined by the MTS [3-(4,5-Dimethylthiazol-2-yl)- 
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, 
inner salt] assay. Mouse macrophage cells RAW264.7 (ATCC, 
Manassas, VA) were seeded at 2*104/well on 96-well cell culture 
plates in Dulbecco’s modified Eagle medium (Corning, Corning, 
NY) supplemented with 5% heat-inactivated fetal bovine serum 
(VWR, Radnor, PA) and 2mM of GlutaMAX (Thermo Fisher, 
Waltham, MA) for 17 hours in a cell incubator (7% CO2, 37°C).
Toxin neutralization efficacy was measured by assessing cell viability 
with 1.4X serial dilutions of rCMG2-Fc variants in the presence 
of a constant amount of LT (PA at 100  ng/ml, LF at 200  ng/
ml). rCMG2-Fc serial dilutions were incubated with LT for 30 min 
at 37°C, and then the mixtures were transferred to the cell plates, 
followed by a 4-h incubation at 37°C, 7% CO2. MTS reagent 
(Promega, Fitchburg, WI) was added to the wells at 20  μl/well, 
following with another 4-h incubation at 37°C, 7% CO2. For 
TNAs with Fc gamma receptors blocked, cells were first treated 
with 2.4G2 antibody (BD Biosciences, San Jose, CA) at the 
concentration of 5 or 10  μg/ml for 15  min, then proceeded to 
the TNA as described above. The plates were gently mixed to 
ensure uniform color distribution in the wells, and then the 
absorbance at 490  nm was read with a 96-well plate reader 
(Molecular Devices, San Jose, CA). The EC50s were calculated 
using GraphPad Prism.
Biolayer Interferometry Analysis
The binding between rCMG2-Fc variants and PA was measured 
in real time by biolayer interferometry (BLI) using an Octet 
RED384 instrument (ForteBio, Fremont, CA). rCMG2-Fc in 1X 
PBS buffer with 1  mM MgCl2 was captured on Anti-hIgG Fc 
Capture Biosensors (ForteBio, Fremont, CA) at the surface density 
resulting in a wavelength shift between 0.8 and 1  nm. PA at 
known concentrations (starting from 5.4 μg/ml, 2X serial dilutions) 
were loaded to the sample plate. Sensors loaded with rCMG2-Fc 
were dipped into PA solutions in the kinetics buffer (ForteBio, 
Fremont, CA) for 300 s, and then switched to the kinetics buffer 
(ForteBio, Fremont, CA) for 600–900  s allowing for dissociation. 
The sensorgrams were fitted with 1:1 binding model using ForteBio 
Data Analysis software (ForteBio, Fremont, CA).
Functional rCMG2-Fc (PA Binding) ELISA
The microplate (Corning, Corning, NY) wells were coated with 
100  μl of PA of anthrax (BEI resources, Manassas, VA) at 
concentration of 2.5  μg/ml for 1  h in 1X PBS buffer, and then 
the plate was blocked with 5% nonfat milk for 30  min. The 
rCMG2-Fc samples in 1X PBS with 1 mM MgCl2 (controls and 
37°C incubated samples) were loaded to the plate, 100  μl per 
well (starting from 2.5 μg/ml, 2.5X serial dilutions). The functional 
rCMG2-Fc bound to the PA was detected with an HRP-conjugated 
goat anti-human IgG (Southern Biotech, Birmingham, AL) at 
concentration of 0.5  μg/ml for 1  h. Plates were washed for three 
times with 1X PBST between steps above, and all the steps were 
done at room temperature. The 37°C incubation was eliminated 
to avoid potential effects on protein activity. The plate was 
developed with 100  μl of TMB substrate (Promega, Fitchburg, 
WI) and stopped by the 100  μl of 1  N HCl. The absorbance 
at 450 nm was read with a microplate reader (Molecular Devices, 
San Jose, CA).
Molecular Dynamics Simulation of  
rCMG2-Fc Glycoforms: Construction 
of Initial Protein Configurations
The atomic coordinates of the von Willebrand factor A domain 
of anthrax toxin receptor capillary morphogenesis protein 2 
(CMG2) were obtained from the protein data bank with 4.3  Å 
resolution X-ray crystallography (PDB ID: 1TZN) (Lacy et  al., 
2004). The atomic coordinates of the fragment crystallizable 
(Fc) region of human Immunoglobulin G were obtained from 
the protein data bank with 2.2  Å (PDB ID: 3SGJ) (Ferrara 
et  al., 2011). Missing residues, de-mutations, and fusion of 
the two crystal structures with the IgG2 hinge linker was 
performed with Modeller 9.16 (Webb and Sali, 2014). All four 
linker cysteines were modeled to participate in symmetric 
inter-chain disulfide bonds. Aglycosylated (Agly), GnGnXF, and 
MAN8 glycoforms of the chimeric dimer CMG2-Fc were 
simulated for 100 ns. In molecular simulations, we used modified 
nomenclatures to specify the simulated glycoform as only the 
predominant glycoform from each variant was simulated.
Glycan Attachment
Glycans for the GnGnXF, and MAN8 glycoforms were attached 
to Asn268 for both monomers. Glycans were attached using 
the glycam.org glycoprotein builder (Woods, 2005). The glycans 
were subsequently sequentially energy minimized through rigid 
rotation about three bonds: Nγprot-C1glycan, Cβprot-Cγprot, and Cαprot-
Cβprot using the minimization scheme outlined in Bernardi et al. 
(2017). Energy was calculated with GROMACS 5.1.4 (Bekker 
et  al., 1993; Berendsen et  al., 1995; Abraham et  al., 2015) 
using the AMBER ff14SB (Maier et al., 2015) and GLYCAM06-j 
(Kirschner et al., 2008) force fields. The lowest energy rotational 
conformer was selected for the initial coordinates of the molecular 
dynamics simulation for each glycoform.
Simulation Setup
About 100  ns simulations of Agly, MAN8, and GnGnXF 
rCMG2-Fc glycoforms were performed in GROMACS with 
the AMBER ff14SB and GLYCAM06-j force fields. The AMBER 
topology files were exported to GROMACS format using 
ACPYPE (da Silva and Vranken, 2012) with updated modifications 
which enable simulations with the GLYCAM forcefield in 
GROMACS (Bernardi et  al., 2019). The 100  ns production 
simulations were first preceded by energy minimization in 
vacuum, solvation, solvated energy minimization, a 100  ps 
NVT equilibration, and finally a 100  ps NPT equilibration. 
Both energy minimizations were terminated with a maximum 
force tolerance of 1,000  kJ  mol−1  nm−1. Each glycoform was 
solvated with explicit water with a minimum distance of 1.2 nm 
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between the glycoprotein and the edge of the periodic box. 
The solvated systems were then neutralized with either sodium 
or chloride ions, and then concentrated to 0.155  M NaCl. The 
velocity-rescale thermostat (Bussi et  al., 2007) was used with 
a reference temperature of 310 K and a time constant of 0.1 ps. 
The isotropic Parrinello-Rahman (Parrinello and Rahman, 1981) 
barostat was used with a reference pressure of 1  bar, a time 
constant of 2  ps, and an isothermal compressibility of 4.5 × 
10−5  bar−1. All nonbonded interactions employed a short-range 
cutoff of 1  nm, with vertically shifted potentials such that the 
potential at the cutoff range is zero. The Particle-Mesh Ewald 
method (Darden et  al., 1993) with cubic interpolation was 
used to model long range electrostatic interactions. All non-water 
bonds were constrained with LINCS (Hess, 2008), while water 
bonds were constrained with SETTLE (Miyamoto and Kollman, 
1992). A 2  fs timestep was used with a sampling interval of 
0.1  ns, for a total of 1,000 data points per 100  ns simulation.
RESULT
Transient Expression of rCMG2-Fc 
Variants
Recombinant CMG2-Fc variants were transiently expressed in 
Nicotiana benthamiana whole plants via agroinfiltration under 
identical conditions, and the expression levels were determined 
in crude leaf extract at 6  days post infiltration (dpi) with a 
sandwich ELISA detecting the Fc domain of rCMG2-Fc. The 
expression level rankings on the leaf fresh weight basis (LFW) 
from high to low were: APO (578 mg/kg LFW), ER (430 mg/kg 
LFW), and Agly (148  mg/kg LFW) variants (Figure 1). Both 
APO and Agly variants, which only differ in the N-glycosylation 
generated by a point mutation of N268Q, were targeted to 
plant Apoplast. The only N-glycosylation site within rCMG2-Fc 
is located at the CH2 domain of IgG1 Fc (N297 in IgG1, N268 
in rCMG2-Fc). The significantly higher expression of the APO 
variant with respect to the Agly variant might be  due to 
stabilizing effects of N-glycans on protein accumulation in planta. 
This observation is consistent with previous studies, where 
proteins are more susceptible to protease cleavage after 
deglycosylation (Liu et  al., 2008; Zheng et  al., 2011). In many 
cases, targeting proteins to the ER will result in a greater 
protein yield compared with targeting to the cytosol or apoplast 
(Pan et  al., 2008; Sainsbury and Lomonossoff, 2008; Pillay 
et  al., 2014). The plant apoplast is usually not a preferred 
location for recombinant protein accumulation given the 
abundance and poor specificity of proteases (Benchabane et al., 
2008; Pillay et  al., 2014). However, in this case, the APO 
variant resulted in a high accumulation, which indicates that 
rCMG2-Fc is stable even in a protease-rich environment when 
glycosylated. Comparing the APO to ER variants, the expression 
levels are similar. Besides the contribution from the high stability 
of rCMG2-Fc in apoplast, it is also possible that the ER variant 
was under-extracted due to the additional ER membrane barrier 
considering that no detergent was used in the extraction buffer.
In Figure 2A, purified rCMG2 of all variants showed a 
dominant band around ~50 kDa, corresponding to the rCMG2-Fc 
monomer, the faint bands below were likely a Fc-containing 
fragment. This observation is consistent with the hypothesis that 
N-glycosylation stabilizes protein in planta, as less degradation 
was found in APO and ER variants than in the Agly variant. 
It was hypothesized that all three variants were degraded at the 
same site(s) as proteolytic cleavage shows some degree of site 
specificity. By N-terminal sequencing of the Fc-containing fragment, 
three cleavage sites were identified within or near the linker of 
rCMG2-Fc, and those sites were shared among variants 
(Supplementary Figure S2). It is not surprising that cleavage 
occurred near the linker region because the linker in rCMG2-Fc 
is flexible and proteases tend to cleave at solvent-exposed, flexible 
and less structured regions (Song et  al., 2012). The SDS-PAGE 
under nonreducing conditions (Figure 2B) reveals that the 
expressed rCMG2-Fc primarily formed a homodimeric species 
(~100  kDa). The lower bands were dimerized Fc-containing 
fragments. The band at 250 kDa in the ER variant sample might 
represent protein aggregate, which was not observed in APO or 
Agly variants, suggesting that the ER variant is prone to aggregation 
more than the other two variants. Western blots detecting CMG2 
(Figure 2C) and Fc (Figure 2D) were conducted to confirm 
the presence of both domains. These two blots confirm the 
existence of both domains, and also confirm that the lower band 
in Figure 2A only contains an Fc fragment. No detectable CMG2 
fragment in Figure 2C confirms that the protein degradation 
happened during in planta production, and rCMG2-Fc remained 
intact during storage once being purified from crude plant extract.
rCMG2-Fc Amino Acid Sequence 
Determination
To confirm the amino acid sequence of rCMG2-Fc variants, 
purified variants were subjected to LC–MS/MS analysis. The 
FIGURE 1 | Recombinant CMG2-Fc levels in crude plant extracts at 6 dpi. 
The expression level rankings from high to low are: APO, ER, and Agly 
variants. Error bars represent standard error of two infiltration batches (Leaves 
from 10 plants per batch).
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A B C D
FIGURE 2 | SDS-PAGE and Western Blots of rCMG2-Fc variants. For SDS-PAGE, (A) ~1 μg of total soluble protein/lane, run under reducing and denaturing 
conditions; (B) ~1 μg of total soluble protein/lane, run under nonreducing and denaturing conditions. For Western blots, (C) ~100 ng of total soluble protein/lane, 
run under reducing and denaturing conditions, detecting CMG2 domain; (D) ~500 ng of total soluble protein/lane, run under reducing and denaturing conditions, 
detecting Fc domain.
FIGURE 3 | Amino acid sequences of the rCMG2-Fc variants compared to the control (theoretical) sequence. Variant coloring: APO (blue), ER (red), and  
Agly (purple).
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N-glycosylation site is highlighted in yellow, and the sequences 
not clearly detected are represented with dashes (Figure 3). The 
point mutation (N268Q) in Agly variant was detected as predicted. 
The sequence coverage with respect to the control (theoretical) 
sequence for the APO, ER, and Agly variants were 95.7, 91.7, 
and 90.6%, respectively. The high sequence coverage with 
both N- and C-terminal predicted sequences confirmed the 
production of full length rCMG2-Fc variants in the plants 
(Figure 3; Supplementary Figure S3).
Mass Spectrometry Analysis of rCMG2-Fc 
N-Glycosylation Profile
To determine the glycoform profile, rCMG2-Fc variants were 
subjected to LC-MS/MS analysis for N-glycosylation identification. 
For the APO variant, 99% of N-glycoforms were plant complex-
type, with the most abundant structure of GnGnXF (Figure 4; 
Supplementary Figure S4), indicating that protein went through 
the secretory pathway and was fully glycosylated as expected. 
For the ER variant, the relative abundance of mannose-type 
N-glycans was 50%, with MAN8 (18%) as the most abundant 
mannose-type structure (Figure 4; Supplementary Figure S4). 
Overall, a complex-type N-glycan (GnGnXF) was the most 
predominant N-glycan (34%). To validation the dMRM methods, 
both APO and ER variants were subjected to glycoproteomic 
analysis. Compounds quantitated in dMRM methods were identified 
in glycoproteomic analysis, and several representative full MS 
spectra for the APO and ER variants are shown in Supplementary 
Figures S5A,B, respectively, with the compounds assigned to 
peaks. Comparing the APO to ER variant, a significant shift 
from plant complex-type to mannose-type N-glycans was observed, 
where about half of rCMG2-Fc was retained in ER upon the 
addition of C-terminal ER retention sequence SEKDEL. Although 
the retention is not perfect, the glycoform profiles of APO and 
ER variants are distinct. This incomplete ER retention agrees 
with previous studies (He et  al., 2012; Roychowdhury et  al., 
2018), where proteins can sometimes escape the ER retention 
signal and progress to downstream N-glycosylation processes. 
The glycan MS data was used to select representative glycoforms 
for molecular dynamics simulations.
Toxin Neutralization Assay
To test the toxin neutralization efficacy of rCMG2-Fc in a 
biologically relevant environment, a cell-based toxin 
neutralization assay (TNA) was developed using a mouse 
macrophage cell line (RAW264.7). Since toxin concentrations 
reported in the literature vary, the concentrations and ratio 
of PA and LF were optimized by toxin titration. A PA 
concentration of 100 ng/ml and an LF concentration of 200 ng/
ml were chosen, as these concentrations resulted in almost 
complete cell killing (97%, Supplementary Figure S6). Once 
the lethal toxin (LT, the combination of PA and LF) concentration 
was fixed, the toxin neutralization efficacy of rCMG2-Fc variants 
was analyzed over a range of rCMG2-Fc concentrations. The 
concentration of intact rCMG2-Fc was determined by SDS-PAGE 
densitometry (Supplementary Figure S7). The dose-response 
curves are shown in Figure 5A, from which the EC50 values 
were determined. The average EC50 values from low to high 
are, 67.6  ng/ml for the APO variant, 83.15  ng/ml for the Agly 
variant, and 128.9  ng/ml for the ER variant, where the EC50 
of the ER variant was statistically different (Figure 5B) from 
the Agly and APO variants (p  <  0.05).
This difference in EC50 could have resulted from the toxin 
neutralization that depended on the Fc gamma receptors (FcγR) 
on macrophages, where the interaction between Fc and FcγR 
on the cell surface contributes to toxin neutralization, which 
in turn lowers the EC50 (Verma et  al., 2009; Ngundi et  al., 
2010). Thus, TNAs with FcγR blocking were performed to 
examine the possible contribution of the FcγR. Cells were 
pre-treated with anti-FcγR antibody 2.4G2 for 15  min prior 
to the TNA. The resulting dose-response curves are shown in 
Figure 5C; Supplementary Figure S8, where the blocked 
FcγR  curves overlap with the control curve (no antibody), 
FIGURE 4 | N-glycosylation composition of rCMG2-Fc variants (ER and APO). The relative abundance of each glycoform is represented as the percentage of total 
signal. The schematic representation and the name of each glycan are listed to the right of the N-glycosylation profile figure, with background color matching with 
the corresponding glycan.
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demonstrating that the FcγR-Fc interaction did not contribute 
to toxin neutralization. The differences in EC50 values could 
result from differences in binding kinetics between rCMG2-Fc 
variants and PA, stability of rCMG2-Fc variants during cell 
culture incubation, or rCMG2-Fc variant conformation. 
Additional experiments including BLI, functional ELISA and 
MD simulation were conducted to evaluate these possibilities.
Binding Kinetics Between rCMG2-Fc  
and PA
The binding kinetics between rCMG2-Fc variants and PA 
were measured in real-time with BLI. The measurements were 
taken at room temperature (25°C) and body temperature (37°C) 
to provide information on how binding kinetics are affected 
by temperature, and potentially explains the difference in EC50 
values. Comparing binding kinetics between rCMG2-Fc variants 
and PA at the same temperature, we  found the association 
rate constant (ka) and the dissociation rate constant (kd) to 
be  similar regardless of protein N-glycosylation (Figure 6). 
BLI sensorgrams and fitting curves are shown in Supplementary 
Figure S9. As temperature was increased from 25 to 37°C, 
higher ka and kd values were obtained (Figure 6) as expected, 
since both binding and dissociation will happen faster at an 
elevated temperature. The equilibrium dissociation constant 
(KD) at both temperatures is on the same order (100 pM–1 nM), 
with slightly lower KD at 37°C, demonstrating a desired strong 
binding between rCMG2-Fc and PA (Table 1). These results 
show that all rCMG2-Fc variants are functional with very 
high binding affinities to PA, and the binding equilibrium 
is not strongly affected by temperature. Comparing with 
previously reported binding kinetics of rCMG2 to PA 
(Wigelsworth et  al., 2004), both ka and kd (Figure 6) are in 
A B C
FIGURE 5 | Neutralization of anthrax lethal toxin by rCMG2-Fc variants. (A): rCMG2-Fc variants at various concentrations were incubated with 100 ng/ml of PA 
and 200 ng/ml of LF for 30 min at 37°C prior to adding to the mouse macrophage cell culture (RAW264.7). Cell viability was measured with an MTS assay. Data 
shown are from one representative experiment out of three replications. Each data point corresponds to the mean of duplicate wells on the sample plate, and error 
bars represent standard error of the mean. (B): TNA EC50 values for rCMG2-Fc variants (*: p < 0.05, ns: p > 0.05; Tukey’s test performed after observing a 
significant difference (p = 0.0009) in one-way ANOVA.) Each bar represents the mean from three separate experiments with duplicate well measurements, with error 
bars representing standard deviation from the means. (C): Toxin neutralization assay using the APO variant with FcγR blocked. Control: without anti-FcγR antibody 
treatment. Two concentrations of anti-FcγR antibody were tested: 5 and 10 μg/ml, which were incubated with macrophages for 15 min prior to rCMG2-Fc addition. 
EC50 values for all three conditions were comparable.
FIGURE 6 | Binding and dissociation rate constants of rCMG2-Fc variants to PA measured at 25 and 37°C were calculated by fitting sensorgrams 
(Supplementary Figure S9) to a Langmuir 1:1 interaction model. The ka and kd values are presented in an on-off rate map with diagonal lines indicating the 
equilibrium dissociation constant (KD). Published binding and dissociation kinetic parameters (Wigelsworth et al., 2004) between rCMG2 and PA are included for 
comparison.
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agreement with our BLI results. Moreover, protein 
N-glycosylation showed no significant impact on binding 
kinetics of rCMG2-Fc to PA, as the average deviations in 
KD values were observed to be  2% (25°C) and 26% (37°C), 
which is considered to be within the experimental error (30%) 
of this method (Kamat and Rafique, 2017).
Thermostability of rCMG2-Fc
Protein stability is an important property of biopharmaceuticals, 
as it is often required that a protein remains stable and 
active during both storage and circulation in the target system 
after injection. To assess the stability of rCMG2-Fc variants 
and understand the EC50 differences observed in TNAs, a 
functional ELISA was developed to measure the amount of 
active rCMG2-Fc (able to bind to PA) after incubation at 
37°C for a range of time periods. Four time periods were 
tested: 1, 2, 3  h and overnight (20  h). Since all three variants 
showed similar binding kinetics in BLI experiments, 
we  hypothesized that the differences in EC50 may result from 
rCMG2-Fc stability differences between variants during the 
8-h cell incubation period at 37°C. With a less stable variant, 
the fraction of functional rCMG2-Fc decays over time, together 
with the fact that CMG2 and PA binding is reversible 
(Wigelsworth et al., 2004), resulting in a higher EC50 compared 
to more stable variants.
The observed binding to PA was the same before and after 
incubation at 37°C for APO and Agly variants (Figures 7A,C). 
For the ER variant, the fraction of functional rCMG2-Fc decayed 
over time, and a significant drop was observed for the overnight 
incubation sample (Figure 7B), which explains the higher EC50 
for the ER variant in the TNA (Figure 5B). The thermostability 
result is in agreement with the TNA results, with stability 
rankings from high to low: APO/Agly then ER variants.
Molecular Dynamics Simulation of  
rCMG2-Fc Glycoforms
Molecular dynamics (MD) simulations of the respective 
predominant glycoform in the three rCMG2-Fc variants were 
performed to obtain high resolution structural and dynamical 
information. The three simulated glycoforms were GnGnXF, 
MAN8, and Agly. These glycoforms were selected according 
to the mass spectrometry analysis, shown in Figure 4. GnGnXF 
is the predominant glycoform of both the APO and ER variants. 
Therefore, the MAN8 glycoform, the second-most expressed 
glycan in the ER variant, was simulated to elucidate differences 
between the APO and ER variants.
Macrostructural Analysis
GnGnXF, MAN8, and Agly rCMG2-Fc glycoforms were each 
independently simulated for 100  ns. Figure 8 shows the initial 
and final conformations of all glycoforms from the simulations. 
The images at t  =  0 are all aligned by the Fc CH2 domain; 
the images at t  =  100  ns are each independently aligned to 
best illustrate macrostructural orientation. For all simulations, 
we see the core structure of the protein remains intact. However, 
there is significant variability in the macrostructural orientation 
of the final structures’ CMG2 and Fc domains. The final 
GnGnXF and Agly structures exhibit significantly contracted 
linkers with respect to the final MAN8 structure, where the 
linker is fully extended. All glycoforms retain accessibility of 
the PA binding site after simulation. This is in agreement with 
the BLI (Figure 6), where all three variants have similar ka 
and kd, and the functional ELISA (Figure 7), where all three 
variants have control curves with similar absorbance level.
To quantitatively characterize the macrostructural differences 
between the GnGnXF, MAN8, and Agly glycoforms, we report 
the center of mass (COM) distance between the CMG2 and 
Fc domains in Figure 9. Among the glycoforms, MAN8 has 
the highest COM distance with the narrowest spread at around 
7.2  nm, GnGnXF and Agly have lower COM distances with 
wider spreads, roughly centered around 6  nm, with the Agly 
COM spread being the widest The significantly higher COM 
of MAN8 than GnGnXF and Agly is visually consistent with 
A B C
FIGURE 7 | Functional ELISA results for the APO (A), ER (B), and Agly (C) rCMG2-Fc variants. Variants were diluted to 2.5 μg/ml and incubated at 37°C for 1, 2, 
3 h and overnight prior to ELISA quantification. Controls were kept at 4°C prior to ELISA. Variants were serially diluted and added to the enzyme immunoassay plate 
precoated with PA. Binding was measured by an ELISA detecting the Fc region. Error bars are smaller than the markers, thus are omitted. All sample treatments 
were done simultaneously under identical conditions.
TABLE 1 | Summary of KD values at 25 and 37°C.
Variants KD (M) at 25°C KD (M) at 37°C
APO 3.9 × 10−10 2.1 × 10−10
ER 3.8 × 10−10 1.5 × 10−10
Agly 3.8 × 10−10 2.4 × 10−10
rCMG2* 4.0 × 10−10 NA
*Published KD (Wigelsworth et al., 2004) between rCMG2 and PA is included in the last 
row for comparison.
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the final conformations in Figure 8. The large spread in Agly 
rCMG2-Fc COM distance is largely due to refolding of the 
flexible residues in and near the LNK region. The COM 
distance temporal profile in Supplementary Figure S10 displays 
a gradual increase in Agly COM distance, which tapers off 
around 80  ns. Thus, the larger spread in Agly COM is due 
to conformational changes during the simulation, not a single 
conformation with increased flexibility. The root mean square 
fluctuation (RMSF) data in Supplementary Figure S11 show 
increased Agly RMSF in and around the LNK region during 
the first 50  ns and a reduction in Agly RMSF during the 
latter 50  ns, which is consistent with the trending exhibited 
in the Agly COM distance.
Backbone RMSD of Ordered Domains
The backbone root mean square deviation (RMSD) of ordered 
domains referenced from the initial and final conformations 
of the CMG2 and Fc regions for all three simulated glycoforms 
is shown in Figure 10. A low RMSD indicates protein folding 
transition is minor and the protein structure is stable. For 
each monomer, the ordered domain of the CMG2 region were 
defined as residues 10–181, while the ordered domains of the 
Fc region were defined as the CH2 and CH3 regions: residues 
210–308 and 315–414, respectively. Each domain’s RMSD was 
fit and referenced independently, and subsequently averaged 
FIGURE 8 | Initial (t = 0) and final (t = 100 ns) conformations of GnGnXF, MAN8, and Agly rCMG2-Fc. The N-terminal CMG2 portion is oriented at the top of each 
image, and the C-terminal Fc portion is oriented at the bottom, covalently joined to the CMG2 portion by a flexible linker (LNK). The glycans are shown in licorice 
representation, attached to the Fc regions at Asn268. The protein secondary structure is colored as follows: α-helix (gray), β-sheet (yellow), 310-helix (orange), turn 
(cyan), and coil (magenta). The PA binding sites are highlighted with green ellipses.
FIGURE 9 | Smoothed probability density functions of the center of mass 
distance between the CMG2 and Fc domains for all three glycoforms. Data 
were smoothed with an averaging window of 0.2 nm.
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to produce the plots in Figure 10. Two RMSD profiles were 
averaged to generate the CMG2 RMSD, and four RMSDs were 
averaged to generate the Fc RMSD for each glycoform.
All RMSDs are below 1.6 Å, indicating a generally conserved 
fold for all the ordered domains of each glycoform. This is 
further confirmed by the secondary structure data, provided 
in Supplementary Figure S12. In general, the RMSD from 
the final structure is lower than that of the initial, indicating 
conformational convergence is progressing throughout the 
simulations. The low RMSD and conserved secondary structure 
in all three simulated glycoforms indicate that there were no 
major refolding events; thus, the reduced activity in the TNA 
(Figure 5A) and the functional ELISA (Figure 7B) of the ER 
variant is likely not due to reduced fold stability. The Fc RMSD 
is noticeably lower than the CMG2 RMSD for the Agly and 
GnGnXF glycoforms, indicating minor fold transitions in the 
CMG2 domains of these glycoforms.
Hydrophobic Solvent Accessible  
Surface Areas
The hydrophobic solvent accessible surface area distributions are 
reported in Figure 11. Hydrophobic SASA is defined as SASA 
that is associated with hydrophobic amino acid residues (ALA, 
GLY, ILE, LEU, MET, PHE, PRO, and VAL). The MAN8 glycoform 
has the highest amount of hydrophobic SASA in the simulation, 
while the aglycosylated has the lowest. Increased hydrophobic 
SASA likely yields a greater aggregation propensity (Fink, 1998).
To elucidate which residues contribute most to the hydrophobic 
SASA difference between MAN8 and Agly, the average per-residue 
hydrophobic SASA was calculated, and the five residues with 
the greatest positive difference of MAN8 minus Agly hydrophobic 
SASA were obtained. These residues were Pro199, Pro201, Leu205, 
and Pro300 of one monomer, and Leu206 of the other monomer. 
All of these residues are located in close proximity to the 
N-terminal region of the Fc domain, shown in Figure 12. 
We  see that these residues are highly spread out in the MAN8 
structure, moderately spread out in the GnGnXF structure, 
and closely associating in the Agly structure. The increased 
SASA in the MAN8 glycoform is consistent with the existence 
of the high molecular weight band in the ER variant at ~250 kDa 
in the SDS-PAGE results (Figure 2B).
DISCUSSION
In this paper, experimental and computational techniques 
were employed to study the effects of N-glycosylation on the 
FIGURE 10 | Backbone RMSD of ordered domains referenced from the initial or final conformations of the CMG2 (top) and Fc (bottom) regions of the GnGnXF, 
MAN8, and Agly glycoforms.
FIGURE 11 | Smoothed probability density functions of the hydrophobic 
SASA for all three rCMG2-Fc glycoforms. Data were smoothed with an 
averaging window of 3 nm2.
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expression, structure, function, and stability for anthrax decoy 
protein rCMG2-Fc.
rCMG2-Fc Expression
N-glycosylation was found to strongly stabilize rCMG2-Fc in 
planta as both APO and ER variants have over two-fold higher 
expression level than the Agly variant, shown in Figure 1. 
The increase in expression level of glycosylated variants could 
be  attributed to a decreased susceptibility of the APO and 
ER  variants to proteases, where the steric hindrance of 
oligosaccharides inhibits proteolytic degradation of glycosylated 
rCMG2-Fc. From a manufacturing standpoint, producing 
glycosylated rCMG2-Fc would require less than half the 
production capacity of the aglycosylated form. Thus, when 
glycosylation is not detrimental, preserving natural 
N-glycosylation sites can enhance protein production. 
Alternatively, retaining the aglycosylated protein in the ER can 
also help improve yield, since the ER has fewer types of 
proteases than the apoplast (Doran, 2006). Furthermore, unlike 
the apoplast, the ER has chaperone proteins to provide folding 
support (Doran, 2006). It is also possible to enhance a 
glycoprotein’s function via modification of the N-glycosylation 
profile during expression. This can be achieved using subcellular 
targeting and/or the co-expression of glycan-processing enzymes 
or addition of enzyme inhibitors in the agroinfiltration buffer. 
For example, high mannose Fc N-glycosylation has been shown 
to enhance antibody-dependent cell-mediated cytotoxicity 
(ADCC), which can be  achieved by targeting the protein to 
the ER or addition of mannosidase I  inhibitor to the 
agroinfiltration buffer or cell culture medium (Yu et  al., 2012; 
Xiong et  al., 2018; Kommineni et  al., 2019). It is worth noting 
that N-glycosylation of Fc is not strictly required when Fc is 
fused to the target protein for the purpose of increasing 
circulation half-life (Souders et  al., 2015).
SDS-PAGE and Western blot confirmed that intact rCMG2-Fc 
was produced, with bands near 50  kDa (Figure 2A). There 
is also a band around 250 kDa in the non-reducing SDS-PAGE 
for the ER variant (Figure 2B), which may correspond to a 
high molecular weight protein aggregate. The hypothesis of 
increased aggregation propensity of the ER variant is supported 
by the hydrophobic SASA predicted from our MD simulations. 
MAN8 was found to have significantly higher hydrophobic 
SASA, with the five strongest contributing residues in the 
N-terminal region of the Fc domain. Protein aggregation might 
FIGURE 12 | Images of the final conformations of the top five rCMG2-Fc residues that contribute to the largest positive differences in time-averaged, per-residue 
hydrophobic SASA of MAN8 minus Agly. The general location of these residues in rCMG2-Fc is depicted by the dashed rectangle in the schematic  
(disulfide bonds are indicated with solid gray lines).
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reduce PA binding capacity, as it is evident in the functional 
ELISA (Figure 7), which is later discussed in the rCMG2-Fc 
function section.
rCMG2-Fc Function
The ability for rCMG2-Fc variants to sequester anthrax PA 
and prevent cell death was assessed using a cell-based TNA. 
Results are shown in Figure 5, where the ER variant has a 
statistically higher EC50 value than APO and Agly variants. 
The possibility of FcγR dependent toxin neutralization (Verma 
et  al., 2009; Abboud et  al., 2010; Ngundi et  al., 2010) was 
ruled out as the EC50 values did not change upon FcγR blocking. 
This is likely because previous studies used antibodies or serum 
against PA that bind to PA but not necessarily blocks the its 
binding site to the anthrax cellular receptor CMG2. Thus, when 
incubated with cells, the antibody-bound PA can still bind to 
CMG2 and form prepore, resulting in LF and EF endocytosis. 
In this situation, Fc and FcγR could form an immune complex 
that is then sorted and degraded in the lysosome (Abboud 
et  al., 2010). In our experiments, rCMG2-Fc competitively 
inhibits binding between cellular receptor CMG2 and PA. This 
completely eliminates LF and EF internalization.
The binding kinetics between rCMG2-Fc variants and PA 
were determined by BLI, results shown in Figure 6. The 37°C 
KD values were slightly lower than the 25°C KD values, but 
no appreciable difference in binding kinetics as a function of 
glycosylation was observed at 25 or 37°C. Considering the 
CMG2 domain is linked to Fc through a flexible linker, it is 
not surprising that the glycosylation of the Fc domain has 
minimal impact on the binding kinetics of the CMG2 domain 
with PA. Moreover, the sub-nanomolar affinity reported in 
this work is consistent with previous work on rCMG2 and 
PA binding kinetics (Wigelsworth et  al., 2004), which is direct 
evidence that neither the fused Fc domain nor its glycosylation 
interferes with CMG2/PA binding kinetics. Even though the 
kinetics of all three variants were unaffected by glycosylation, 
it is possible that the fraction of functional protein changes 
over time. The BLI experiments only characterized the interaction 
kinetics, which are independent of the fraction of functional 
rCMG2-Fc on the sensor tip.
The hypothesis that the fraction of functional protein at 
37°C is glycosylation-dependent was confirmed with the 
functional rCMG2-Fc ELISA, where the ER variant lost the 
most activity overnight, consistent with the ER variant having 
the highest EC50. However, the MD simulation data exhibit 
high fold stability in all glycoforms, according to the RMSD 
of ordered domains (Figure 10) as well as the secondary 
structure (Supplementary Figure S12). Thus, we  hypothesize 
that the reduction in activity is not due reduced fold stability. 
Moreover, the MAN8 had the highest hydrophobic SASA 
among the three simulated glycoforms, indicating a higher 
aggregation propensity. The residues that contributed the most 
to the decreased hydrophobic SASA in the simulated Agly 
from the MAN8 were located in the N-terminal region of 
the Fc domain, just after the C-terminal region of the linker 
(Figure 12). This region is also more extended in the MAN8 
glycoform, as shown in the final conformation (Figure 8) 
and the COM distance distribution (Figure 9). This exposure 
of hydrophobic residues in the thinly extended N-terminal 
region of the Fc domain could facilitate the aggregation with 
other rCMG2-Fc or protein fragments. This could explain the 
reduced activity for ER variant in the functional ELISA 
(Figure 7) and the 250 kDa band observed in the nonreducing 
SDS-PAGE gel for the ER variant (Figure 2B). Fusion protein 
aggregation has been observed in the literature for another 
Fc fusion protein ALK1-Fc, where a high abundance of MAN5 
glycoform was found as high molecular weight aggregates 
(Strand et  al., 2013). It is worth noting that a recent study 
on high-mannose type IgG showed a decrease in protection 
factors of backbone amide nitrogen in the CH2 domain (Fang 
et al., 2016), which could also contribute to the reduced activity 
of the ER variant. Meanwhile, Lu et  al., found that high-
mannose glycans have no detrimental effect on antibody stability 
and aggregate rate (Lu et  al., 2012). The antibodies used in 
their study were IgG1 and IgG2, which has a molecular weight 
~150 kDa. Since both the protein size and structure can affect 
protein stability, it is not surprising to see diverse protein 
stability results performed on different molecules. Within 
Fc-fusion proteins, structure can still vary depending on the 
fusion partner size and structure. However, we  do expect 
Fc-fusion proteins with similar structure, molecular weight 
and conserved glycosylation site as rCMG2-Fc to likely exhibit 
similar behaviors.
The APO and Agly variants had no significant difference 
in fraction of functional protein after being incubated overnight 
at 37°C. This result is in agreement with a previous study 
where human IgG1s (complex N-glycan and aglycosylated) 
stored at 37°C for 21  days had no difference in aggregation 
or fragmentation (Hristodorov et  al., 2013), suggesting the 
absence of glycans had no major impact on stability under 
physiological temperature. A previous study of rCMG2-Fc 
using a different linker exhibited variants with oligomannose 
glycan or no glycan and had similar TNA EC50 values for 
both variants (Wycoff et  al., 2011), while our data indicate 
a significant increase in EC50 for the ER (oligomannose) 
variant over the APO and Agly variants. The linker used in 
Wycoff et  al.’s (2011) study and this study were two serine 
residues followed by the upper hinge of IgG1 (SSEPKSCDKTHT) 
and IgG2 (SSERKCCVE), respectively. These linkers differ in 
both length and sequence. This study utilizes the IgG2 hinge 
to enhance protein dimerization due to the two additional 
cysteine residues for inter-hinge disulfide bond formation. 
Since both linker sequence and length can affect stability 
and function of fusion proteins (Chen et  al., 2013; Lee et  al., 
2013), thus, it is not surprising to see a difference in toxin 
neutralization ability.
In this study, the expressed N-glycosylation variants were 
not found to functionally affect rCMG2-Fc/PA binding. However, 
protein expression, integrity and thermostability were affected 
by glycosylation. The APO variant showed the best overall 
performance with a high expression level, high protein integrity 
and thermostability. However, the debate on plant complex-
type N-glycosylation is ongoing. It has been shown that plant 
complex N-glycans are immunogenic by the detection of 
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anti-plant glycoepitopes antibodies in human sera (Gomord 
et  al., 2005), despite that no adverse effects were observed 
when plant-made pharmaceuticals (PMPs) with complex 
N-glycans were applied to patients with IgE against plant 
glycoforms (Ma et  al., 1998; Zeitlin et  al., 1998; Mari et  al., 
2008). In addition, the plant β1,2-xylose and α1,3-fucose moieties 
can potentially induce rapid clearance from circulation due to 
the presence of IgE against those epitopes. Similarly, variants 
containing mannose-type N-glycans can lead to a shorter 
circulation half-life compared to the Agly variant, due to the 
presence of mannose receptor in serum (Goetze et  al., 2011). 
However, the shorter half-life of rCMG2-Fc variants (APO 
and ER) can turn into an advantage when using as a post-
exposure treatment (dosing is not limited), resulting in fast 
blood clearance of decoy-toxin complex. For prophylaxis, the 
Agly variant is likely the best option, considering its longer 
circulation half-life than other two variants.
Summary and Future Perspectives
Glycosylation variants of an anthrax decoy protein rCMG2-Fc 
were successfully produced in Nicotiana benthamiana plants 
with distinct N-glycosylation patterns. The expression levels 
were in the range of 148–578 mg/kg LFW. The N-glycosylation 
profiles, characterized by mass spectrometry, were 50% high-
mannose type for the ER variant and 99% complex-type for 
the APO variant. The rCMG2-Fc variants were all functional 
with sub-nanomolar dissociation rate constants regardless of 
N-glycosylation pattern. The higher EC50 of the ER variant 
compared with the APO and Agly variants was likely due to 
the loss of activity during the 37°C incubation condition used 
in the TNA assay. The loss of activity could be  explained by 
increased aggregation of the ER variant, consistent with the 
SDS-PAGE and MD simulation results. To better assess the 
effects of N-glycosylation on protein properties, in vitro enzymatic 
glycan modification can be employed to express more uniform 
glycoforms. This avoids glycan heterogeneity, allowing a more 
accurate comparison between experimental and MD simulation 
data. Moreover, other proteins, especially Fc-fusion proteins 
can be  studied using the methodology provided in this work 
to assess the applicability of our findings and to optimize 
glycoprotein therapeutic design.
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